Good practice: The experiences with the utilization of residual cancer burden-A single institution study.

Anita Sejben,Fanni Hegedűs,Szintia Almási, Márton Berta,Orsolya Oláh-Németh,Tamás Zombori

Thoracic cancer（2023）

引用 1|浏览1

暂无评分

摘要

Significant agreement was observed between examiners based on almost all RCB parameters, points, and classes, reflecting the optimal reproducibility of RCB. Therefore, we recommend the use of the calculator in routine histopathological reports in NAT cases.

查看译文

关键词

breast cancer,neoadjuvant therapy,reproducibility,residual cancer burden

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要